boronic acid beta-lactamase inhibitors (TheraBor)

N/A

Report date: 2025/03/14 16:49:44
NME

Base Information

Drug Nameboronic acid beta-lactamase inhibitors (TheraBor)
Drug Alias NameAmpC beta-lactamase inhibitors (University of Modena/Northwestern University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsMultidrug-Resistant InfectionBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Modena And Reggio Emilia
China Registration ClassN/A

Develop Information

Active CompaniesTheraBor Pharmaceuticals
Inactive CompaniesUniversity Of Modena And Reggio Emilia
Active IndicationsMultidrug-Resistant InfectionBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A